163 related articles for article (PubMed ID: 24412993)
1. Histologic evaluation of ulcerative colitis: a systematic review of disease activity indices.
Mosli MH; Feagan BG; Sandborn WJ; Dʼhaens G; Behling C; Kaplan K; Driman DK; Shackelton LM; Baker KA; Macdonald JK; Vandervoort MK; Geboes K; Levesque BG
Inflamm Bowel Dis; 2014 Mar; 20(3):564-75. PubMed ID: 24412993
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis.
Mohammed Vashist N; Samaan M; Mosli MH; Parker CE; MacDonald JK; Nelson SA; Zou GY; Feagan BG; Khanna R; Jairath V
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011450. PubMed ID: 29338066
[TBL] [Abstract][Full Text] [Related]
3. Histologic scoring indices for evaluation of disease activity in ulcerative colitis.
Mosli MH; Parker CE; Nelson SA; Baker KA; MacDonald JK; Zou GY; Feagan BG; Khanna R; Levesque BG; Jairath V
Cochrane Database Syst Rev; 2017 May; 5(5):CD011256. PubMed ID: 28542712
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of the measurement of endoscopic healing in ulcerative colitis clinical trials: recommendations and implications for future research.
Samaan MA; Mosli MH; Sandborn WJ; Feagan BG; DʼHaens GR; Dubcenco E; Baker KA; Levesque BG
Inflamm Bowel Dis; 2014 Aug; 20(8):1465-71. PubMed ID: 24831558
[TBL] [Abstract][Full Text] [Related]
5. Assessment of histologic disease activity in Crohn's disease: a systematic review.
Mojtahed A; Khanna R; Sandborn WJ; D'Haens GR; Feagan BG; Shackelton LM; Baker KA; Dubcenco E; Valasek MA; Geboes K; Levesque BG
Inflamm Bowel Dis; 2014 Nov; 20(11):2092-103. PubMed ID: 25137418
[TBL] [Abstract][Full Text] [Related]
6. Applicability of endoscopic indices in the determination of disease activity in patients with ulcerative colitis.
Kucharski M; Karczewski J; Mańkowska-Wierzbicka D; Karmelita-Katulska K; Grzymisławski M; Kaczmarek E; Iwanik K; Rzymski P; Swora-Cwynar E; Linke K; Dobrowolska A
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):722-30. PubMed ID: 26894632
[TBL] [Abstract][Full Text] [Related]
7. Review article: the histological assessment of disease activity in ulcerative colitis.
Marchal Bressenot A; Riddell RH; Boulagnon-Rombi C; Reinisch W; Danese S; Schreiber S; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2015 Oct; 42(8):957-67. PubMed ID: 26304292
[TBL] [Abstract][Full Text] [Related]
8. Is mucosal healing more common than clinical remission in ulcerative colitis? - Is it the truth or only a myth coming from the studies?
Rutka M; Milassin Á; Szepes Z; SzŰcs M; Nyári T; Bálint A; Bor R; Molnár T; Farkas K
Scand J Gastroenterol; 2015 Aug; 50(8):985-90. PubMed ID: 25733077
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set.
Ma C; Panaccione R; Fedorak RN; Parker CE; Nguyen TM; Khanna R; Siegel CA; Peyrin-Biroulet L; D'Haens G; Sandborn WJ; Feagan BG; Jairath V
Clin Gastroenterol Hepatol; 2018 May; 16(5):637-647.e13. PubMed ID: 28843356
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of measurement of endoscopic disease activity and mucosal healing in Crohn's disease: recommendations for clinical trial design.
Khanna R; Bouguen G; Feagan BG; DʼHaens G; Sandborn WJ; Dubcenco E; Baker KA; Levesque BG
Inflamm Bowel Dis; 2014 Oct; 20(10):1850-61. PubMed ID: 25029615
[TBL] [Abstract][Full Text] [Related]
11. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
[TBL] [Abstract][Full Text] [Related]
12. Histological Disease Activity as a Predictor of Clinical Relapse Among Patients With Ulcerative Colitis: Systematic Review and Meta-Analysis.
Park S; Abdi T; Gentry M; Laine L
Am J Gastroenterol; 2016 Dec; 111(12):1692-1701. PubMed ID: 27725645
[TBL] [Abstract][Full Text] [Related]
13. A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis.
Turner D; Seow CH; Greenberg GR; Griffiths AM; Silverberg MS; Steinhart AH
Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1081-8. PubMed ID: 19577010
[TBL] [Abstract][Full Text] [Related]
14. Rectal 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Marshall JK; Thabane M; Steinhart AH; Newman JR; Anand A; Irvine EJ
Cochrane Database Syst Rev; 2010 Jan; (1):CD004115. PubMed ID: 20091560
[TBL] [Abstract][Full Text] [Related]
15. The emerging role of histologic disease activity assessment in ulcerative colitis.
Pai RK; Jairath V; Vande Casteele N; Rieder F; Parker CE; Lauwers GY
Gastrointest Endosc; 2018 Dec; 88(6):887-898. PubMed ID: 30142351
[TBL] [Abstract][Full Text] [Related]
16. Systematic review: histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative.
Bryant RV; Winer S; Travis SP; Riddell RH
J Crohns Colitis; 2014 Dec; 8(12):1582-97. PubMed ID: 25267173
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Curcumin as Adjuvant Therapy to Induce or Maintain Remission in Ulcerative Colitis Patients: an Evidence-based Clinical Review.
Simadibrata M; Halimkesuma CC; Suwita BM
Acta Med Indones; 2017 Oct; 49(4):363-368. PubMed ID: 29348389
[TBL] [Abstract][Full Text] [Related]
18. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model.
Archer R; Tappenden P; Ren S; Martyn-St James M; Harvey R; Basarir H; Stevens J; Carroll C; Cantrell A; Lobo A; Hoque S
Health Technol Assess; 2016 May; 20(39):1-326. PubMed ID: 27220829
[TBL] [Abstract][Full Text] [Related]
19. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
20. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
